Cleared Special

K222655 - OtoSight Middle Ear Scope (FDA 510(k) Clearance)

Sep 2022
Decision
24d
Days
Class 2
Risk

K222655 is an FDA 510(k) clearance for the OtoSight Middle Ear Scope. This device is classified as a Device System, Imaging, Tympanic Membrane And Middle Ear (Class II - Special Controls, product code QJG).

Submitted by Photonicare, Inc. (Champaign, US). The FDA issued a Cleared decision on September 26, 2022, 24 days after receiving the submission on September 2, 2022.

This device falls under the Ear, Nose, Throat FDA review panel. Regulated under 21 CFR 892.1560. Is Intended For Use As An Imaging Tool For Visualization Of The Human Tympanic Membrane And Middle Ear Space..

Submission Details

510(k) Number K222655 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 02, 2022
Decision Date September 26, 2022
Days to Decision 24 days
Submission Type Special
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF

Device Classification

Product Code QJG - Device System, Imaging, Tympanic Membrane And Middle Ear
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1560
Definition Is Intended For Use As An Imaging Tool For Visualization Of The Human Tympanic Membrane And Middle Ear Space.